Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
4.480
-0.010 (-0.22%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Mersana Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-171.67-204.21-170.06-88.05-28.21-64.26-38.71-13.7-16.43
Depreciation & Amortization
4.33.72.681.011.251.260.930.660.3
Share-Based Compensation
21.1421.5218.417.174.873.881.420.670.35
Other Operating Activities
-22.65129.628.985.17-45.653.9-6.3243.976.15
Operating Cash Flow
-168.88-49.36-139.99-74.7-67.74-55.22-42.6831.59-9.64
Capital Expenditures
-2.17-2.2-0.65-0.47-0.61-1.37-1.14-1.08-0.62
Change in Investments
122.05-150.52037.5-26.6988.57-98.4800
Other Investing Activities
---------0.16
Investing Cash Flow
119.88-152.72-0.6537.03-27.2987.2-99.62-1.08-0.78
Share Issuance / Repurchase
95.09153.2945.56230.7392.831.0668.60.110
Debt Issued / Paid
-0.41-0.2718.34-0.314.880000
Other Financing Activities
---0.26----58.159.96
Financing Cash Flow
94.68153.0263.65230.4197.71.0668.658.269.96
Net Cash Flow
45.68-49.06-76.99192.742.6733.04-73.7188.76-0.46
Free Cash Flow
-171.05-51.56-140.64-75.17-68.35-56.59-43.8230.5-10.26
Free Cash Flow Margin
-464.12%-193.97%-327060.47%-9078.38%-162.26%-534.13%-249.77%121.19%-99.00%
Free Cash Flow Per Share
-1.47-0.55-1.99-1.22-1.57-2.46-3.6524.08-8.38
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).